Sana Biotechnology, Inc. (SANA)
NASDAQ: SANA · Real-Time Price · USD
3.070
-0.080 (-2.54%)
At close: May 22, 2026, 4:00 PM EDT
3.110
+0.040 (1.30%)
After-hours: May 22, 2026, 7:01 PM EDT
Sana Biotechnology Market Cap
Sana Biotechnology has a market cap or net worth of $854.36 million as of May 22, 2026. Its market cap has increased by 109.27% in one year.
Market Cap
854.36M
Enterprise Value
835.85M
1-Year Change
109.27%
Ranking
Category
Stock Price
$3.07
Market Cap Chart
Since the IPO on February 4, 2021, Sana Biotechnology's market cap has decreased from $1.33B to $854.36M, a decrease of -35.52%. That is a compound annual growth rate of -7.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 854.36M | -21.19% |
| Dec 31, 2025 | 1.08B | 197.89% |
| Dec 31, 2024 | 363.93M | -54.75% |
| Dec 29, 2023 | 804.30M | 7.21% |
| Dec 30, 2022 | 750.19M | -73.52% |
| Dec 31, 2021 | 2.83B | 113.84% |
| Feb 4, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Annexon | 870.00M |
| ORIC Pharmaceuticals | 861.27M |
| Arbutus Biopharma | 859.29M |
| MeiraGTx Holdings | 855.71M |
| Cullinan Therapeutics | 850.58M |
| Theravance Biopharma | 843.92M |
| Xencor | 838.54M |
| Aura Biosciences | 838.28M |